12/20/2023 | BK | Integra pushes $150 million securitization facility maturity to 2026
|
5/23/2023 | CV | Market Commentary: Integra LifeSciences convertible notes in focus on product recall; Welltower below par
|
5/23/2023 | CV | Market Commentary: Morning Commentary: Integra LifeSciences convertible notes in focus on product recall
|
6/1/2022 | CV | Market Commentary: ConMed convertible notes offering eyed; Integra LifeSciences active; Beyond Meat higher
|
9/30/2020 | CV | Market Commentary: Convertibles trading quiet; Oasis Petroleum in focus on bankruptcy; Integra gains
|
2/24/2020 | CV | Market Commentary: Exact Sciences brings overnight deal; convertibles secondary market weak; Tesla active
|
2/18/2020 | CV | Market Commentary: Pegasystems convertible notes, NextEra Energy equity units on tap; Integra improves
|
2/7/2020 | CV | Integra LifeSciences greenshoe ups 0.5% convertibles to $575 million
|
2/6/2020 | CV | Market Commentary: Smart Global convertibles on tap; PAR expands on debut; Weibo active; Twitter expands
|
2/5/2020 | CV | Market Commentary: PAR Technology convertibles eyed; Integra expands on debut; Tesla comes in; Snap expands
|
2/5/2020 | CV | Market Commentary: Morning Commentary: Integra hits secondary market; PAR Technology eyed; Snap expands
|
2/4/2020 | CV | New Issue: Integra LifeSciences prices $500 million 0.5% 5.5-year convertibles, up 30%
|
2/4/2020 | CV | Market Commentary: PAR Technology on tap; Integra convertibles eyed; Tesla’s rise continues; Lumentum up
|
2/4/2020 | CV | Market Commentary: Morning Commentary: Integra convertible notes offering eyed; Tesla’s rise continues
|
2/4/2020 | CV | Integra LifeSciences pricing $500 million five-year convertibles after Tuesday market close
|
2/3/2020 | CV | Market Commentary: Integra convertibles on tap; Tesla ‘a beast’; Luckin Coffee volatile; Insmed expands
|
2/3/2020 | CV | Integra LifeSciences talks $500 million five-year convertibles at 0.375%-0.875%, up 27.5%-32.5%
|
2/3/2020 | BK | Integra enters into $2.18 billion of amended and restated facilities
|
5/7/2018 | BK | Integra LifeSciences extends, betters pricing of $2.2 billion facility
|
10/2/2017 | BK | Integra LifeSciences borrows $700 million delayed-draw term loan A
|
4/4/2017 | BK | Integra adds $700 million term loan A for Codman Neurosurgery purchase
|
2/15/2017 | BK | Integra plans new term loan for Codman Neurosurgery purchase
|
1/11/2017 | BK | Integra LifeSciences to fund Derma buy with credit facility borrowings
|
1/11/2017 | CVLM | Integra tenders for Derma Sciences series A, B convertible preferreds
|
12/7/2016 | BK | Integra LifeSciences lifts facility to $1.5 billion, extends to 2021
|
9/1/2015 | BK | Integra adds $200 million in term loans under credit agreement
|
12/29/2014 | BK | Integra LifeSciences amends credit facility to permit SeaSpine dividend
|
7/9/2014 | BK | Integra LifeSciences amends $900 million facility with Bank of America
|
6/24/2013 | BK | Integra LifeSciences amends some covenants to increase borrowing
|
4/22/2013 | CV | Market Commentary: Integra LifeSciences flat to lower; Vertex quiet after surge; Intel, Microsoft in trade
|
6/4/2012 | BKCV | Integra pays down 2.375% convertibles with revolver borrowings
|
9/12/2011 | BK | Integra LifeSciences to tap LoC for Ascension Orthopedics acquisition
|
6/15/2011 | CV | Integra greenshoe fully exercised, convertibles lifted to $230 million
|
6/10/2011 | CV | New Issue: Integra LifeSciences prices $200 million 5.5-year convertibles at 1.625%, up 23%
|
6/10/2011 | CV | Market Commentary: Molycorp jumps on debut, but Integra drops; new Brookside extends losses; Vertex expands
|
6/9/2011 | CV | Market Commentary: Brookdale slips on debut; Forestar scraps deal; Molycorp looks cheap after revised talk
|
6/9/2011 | BK | Integra to pay down senior credit facility with convertibles proceeds
|
6/9/2011 | CV | Integra LifeSciences to sell $200 million five-year convertibles at 1.25%-1.75%, up 22.5%-27.5%
|
6/8/2011 | BK | Integra LifeSciences amends $600 million facility with Bank of America
|
3/1/2010 | CV | Integra LifeSciences buys back $18.6 million of its 2.75% convertibles
|
5/6/2009 | CV | Integra LifeSciences buys back $32.1 million in 2.75% senior convertible notes due 2010
|
5/16/2008 | CVDD | Integra to pay penalty interest, damages on 2.75%, 2.375% senior convertibles
|
3/5/2008 | CV | Integra Lifesciences secures bank loan needed to repay 2.5% convertibles due 2008
|
2/20/2008 | CV | Integra 2.5% convertibles holders to receive contingent interest
|
6/19/2007 | SS | Essig reports 7.1% stake in Integra LifeSciences
|
6/11/2007 | CV | Integra greenshoe fully exercised, bringing convertibles to $330 million
|
6/6/2007 | CV | New Issue: Integra sells $300 million convertibles: three years at 2.75%, up 27.5%, five years at 2.375%, up 25%
|
6/6/2007 | CV | Market Commentary: Integra leads new deals with debut gain; Ciena gains dollar-neutral; Dendreon, Cogent set cheaper than talk
|
6/5/2007 | CV | Market Commentary: Amylin gains on debut; Integra higher, Ciena, Dendreon quiet in gray; Cogent, Panda launch unusual deals
|
6/4/2007 | CV | Integra to price $250 million three-, five-year convertibles in two tranches Tuesday after close
|
6/4/2007 | CV | Market Commentary: Solectron surges on buyout; Amylin flat in gray; Dendreon faces borrow problem; Integra, Ciena plan deals
|
10/26/2006 | BTCV | Integra LifeSciences exchanges $4.337 million 2.5% convertibles
|
10/2/2006 | BTCV | Integra LifeSciences exchanges $115.205 million 2.5% convertibles
|
8/28/2006 | BTCV | Integra LifeSciences prolongs exchange for 2.5% convertibles, adds takeover protection
|
8/14/2006 | BTCV | Integra LifeSciences waives minimum participation condition in exchange for 2.5% convertibles
|
8/2/2006 | BT | Integra reports $8.0 million second quarter net income
|
7/31/2006 | BTCV | Integra LifeSciences modifies net share settlement exchange for 2.5% convertibles
|
7/17/2006 | BTCV | Integra LifeSciences begins net share settlement exchange for 2.5% convertibles
|
7/11/2006 | BT | Integra LifeSciences acquires distributor Canada Microsurgical for C$6.4 million
|
6/30/2006 | BT | Integra LifeSciences to acquire Kinetikos for $40 million
|
4/25/2006 | BT | Integra LifeSciences to present results of Licox Brain Tissue Oxygen Monitoring studies at meeting
|
4/24/2006 | BT | Integra adds Radionics' CUSA brand to its ultrasonic aspirator products
|
4/20/2006 | BT | Integra LifeSciences to acquire Miltex in $101 million cash deal
|
12/22/2005 | BT | Integra LifeSciences gets $200 million revolver
|
8/8/2005 | BT | Integra LifeSciences repurchases 0.75 million shares for $24.7 million during second quarter
|
4/11/2003 | CV | Integra says greenshoe exercised, raising convertibles to $120 million
|
3/28/2003 | CV | Market Commentary: Continental, Alaska Air dive; Fleming feeds liquidity fears; warnings signal selling spree
|
3/26/2003 | CV | Market Commentary: Integra prices drive-by deal, energy issues spotlighted by $3.3 billion California refunds
|
3/26/2003 | CV | New Issue: Integra Lifesciences drive-by $100 million convertibles at 2.5%, up 44.89%
|